Effect of human immunodeficiency virus type 1 (HIV-1) monocyte-derived macrophages infection on the manganous superoxide dismutase gene expression. NLM AIDSLINE Important note: Information in this article was accurate in 1994. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Effect of human immunodeficiency virus type 1 (HIV-1) monocyte-derived macrophages infection on the manganous superoxide dismutase gene expression.

Chem Biol Interact. 1994 Jun;91(2-3):123-31. Unique Identifier : AIDSLINE MED/94251838
Raoul H; Mabondzo A; Le Naour R; Dormont D; Laboratoire de Neuropathologie experimentale et Neurovirologie,; CRSSA/DSV/DPTE, Commissariat a l'Energie Atomique, Fontenay aux; Roses, France.


Abstract: Clinical and biological features indicate that a dysregulation of microbicidal activity occurs in the cells of mononuclear phagocytic lineage of HIV-1-infected patients. Thus, the regulation of MnSOD gene expression has been investigated during the 10 h following in vitro HIV macrophage infection. As previously reported, in HIV-1 LAI-infected macrophages a high expression of the MnSOD gene is observed 2 and 4 h after infection. These results are confirmed when cells are infected with three macrophage-tropic strains HIV-1, DAS, PAR and Bal. Moreover, the detection of the MnSOD gene expression in the macrophage cultures is associated with the cellular tropism of the viral strains used. The binding of recombinant GP160 by itself is not sufficient to induce MnSOD expression. In fact, the same MnSOD gene induction was obtained with the heat inactivated viral isolates, indicating that these phenomena are due to the viral entry. On the other hand, phagocytosis of latex beads triggers a high expression of the MnSOD gene in macrophages, showing that phagocytosis of HIV may be sufficient to induce the expression of that gene. Taken together, these results indicate that the MnSOD gene expression observed within 10 h following infection of macrophages is mainly related to membrane biophysical unspecific modifications.
Keywords: Blotting, Northern Cells, Cultured Endocytosis *Gene Expression Regulation, Enzymologic Gene Products, env/METABOLISM Human HIV-1/*PHYSIOLOGY Macrophages/ENZYMOLOGY/*MICROBIOLOGY Monocytes Protein Precursors/METABOLISM Recombinant Proteins/METABOLISM Superoxide Dismutase/BIOSYNTHESIS/*GENETICS Support, Non-U.S. Gov't Transcription, Genetic JOURNAL ARTICLE

KWDblotting,northerncells,culturedendocytosisKWDgeneexpressionregulation,enzymologicgeneproducts,env/metabolismhumanhiv-1/KWDphysiologymacrophages/enzymology/KWDmicrobiologymonocytesproteinprecursors/metabolismrecombinantproteins/metabolismsuperoxidedismutase/biosynthesis/KWDgeneticssupport,non-uKWDsKWDgov'ttranscription,geneticjournalarticle
940930
M9491010


Copyright © 1994 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1994. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1994. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .